BE889182A - Procede de preparation de mutants nouveaux de virus d'herpes simplex type 1 ou type 2, virus mutants ainsi obtenus, vaccins prepares a partir de ceux-ci, procede pour la preparation de tels vaccins et utilisations therapeutiques et pharmacologiques - Google Patents

Procede de preparation de mutants nouveaux de virus d'herpes simplex type 1 ou type 2, virus mutants ainsi obtenus, vaccins prepares a partir de ceux-ci, procede pour la preparation de tels vaccins et utilisations therapeutiques et pharmacologiques

Info

Publication number
BE889182A
BE889182A BE6/47470A BE6047470A BE889182A BE 889182 A BE889182 A BE 889182A BE 6/47470 A BE6/47470 A BE 6/47470A BE 6047470 A BE6047470 A BE 6047470A BE 889182 A BE889182 A BE 889182A
Authority
BE
Belgium
Prior art keywords
preparation
vaccines
type
viruses
therapeutic
Prior art date
Application number
BE6/47470A
Other languages
English (en)
Original Assignee
Asta Werke Ag Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Werke Ag Chem Fab filed Critical Asta Werke Ag Chem Fab
Publication of BE889182A publication Critical patent/BE889182A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16661—Methods of inactivation or attenuation
    • C12N2710/16663—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BE6/47470A 1980-06-12 1981-06-11 Procede de preparation de mutants nouveaux de virus d'herpes simplex type 1 ou type 2, virus mutants ainsi obtenus, vaccins prepares a partir de ceux-ci, procede pour la preparation de tels vaccins et utilisations therapeutiques et pharmacologiques BE889182A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8019308 1980-06-12

Publications (1)

Publication Number Publication Date
BE889182A true BE889182A (fr) 1981-12-11

Family

ID=10514018

Family Applications (1)

Application Number Title Priority Date Filing Date
BE6/47470A BE889182A (fr) 1980-06-12 1981-06-11 Procede de preparation de mutants nouveaux de virus d'herpes simplex type 1 ou type 2, virus mutants ainsi obtenus, vaccins prepares a partir de ceux-ci, procede pour la preparation de tels vaccins et utilisations therapeutiques et pharmacologiques

Country Status (7)

Country Link
US (1) US4322404A (fr)
BE (1) BE889182A (fr)
DE (1) DE3122669A1 (fr)
ES (1) ES8303522A1 (fr)
FR (1) FR2484446A1 (fr)
IT (1) IT8148649A0 (fr)
NL (1) NL8102827A (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554159A (en) * 1981-11-12 1985-11-19 Institute Merieux Vaccine and method of immunizing against herpes simplex virus (types 1 and 2)
GB8305323D0 (en) * 1983-02-25 1983-03-30 Baylor College Medicine Infectious bovine rhinotracheitis vaccine
NL8303501A (nl) * 1983-10-12 1985-05-01 Centraal Diergeneeskundig Inst Deletiemutant van een herpesvirus en vaccin, dat dit virus bevat.
USRE33772E (en) * 1983-10-12 1991-12-17 Centraal Diergeneeskundig Instituut Deletion mutant of a herpesvirus and vaccine containing said virus
US4820514A (en) * 1985-12-30 1989-04-11 Texas A&M University System Low dosage of interferon to enhance vaccine efficiency
US5585096A (en) * 1994-06-23 1996-12-17 Georgetown University Replication-competent herpes simplex virus mediates destruction of neoplastic cells
US5837262A (en) * 1994-07-27 1998-11-17 Bio-Virus Research Incorporated Pharmaceutical compositions against several herpes virus infections and/or atherosclerotic plaque
US6471965B1 (en) * 1994-07-27 2002-10-29 Bio-Virus Research Incorporated Vaccine containing whole killed herpes viruses to prevent development of atherosclerotic plaque
AU2003249990B2 (en) * 2002-07-09 2007-06-28 Takeda Pharmaceutical Company Limited Animal protein free media for cultivation of cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR216081A1 (es) * 1976-07-02 1979-11-30 Dso Pharmachim Un metodo de preparar un mutante virosico avirulento a partir del virus de aujeszky
DE2714665A1 (de) * 1977-04-01 1978-10-05 Mayr Anton Praeparat zur behandlung von herpes zoster und anderen herpes-infektionen, sowie verfahren zu seiner herstellung

Also Published As

Publication number Publication date
DE3122669A1 (de) 1982-02-11
US4322404A (en) 1982-03-30
ES502965A0 (es) 1983-02-01
ES8303522A1 (es) 1983-02-01
NL8102827A (nl) 1982-01-04
FR2484446A1 (fr) 1981-12-18
IT8148649A0 (it) 1981-06-10

Similar Documents

Publication Publication Date Title
BE881014A (fr) Procede de preparation d'organopolysiloxanes, et produits ainsi obtenus
BE889182A (fr) Procede de preparation de mutants nouveaux de virus d'herpes simplex type 1 ou type 2, virus mutants ainsi obtenus, vaccins prepares a partir de ceux-ci, procede pour la preparation de tels vaccins et utilisations therapeutiques et pharmacologiques
FR2540490B1 (fr) Procede de resolution d'isomeres optiques, les isomeres ainsi produits et leur application pharmaceutique
FR2643073B1 (fr) Procede de preparation d'extraits polyphenoliques de type flavane-3-ol purifies et extraits obtenus
FR2565231B1 (fr) Procede de preparation d'organosilanes et d'organopolysilanes a partir d'organodisilanes
FR2558166B1 (fr) Procede de preparation d'un polymere hydrosoluble de haut poids moleculaire
HUT59600A (en) Process for producing pharmaceutical compositions containing 5-methyl-isoxazoe-4-carboxylik-anilides or alpha-/2-hydroxy-ethylidene/-alpha-cyano-acetic-anilides for treating eye-diseases
MC1440A1 (fr) Derives de la pyrrolidine,sa preparation et ses utilisations therapeutiques pour le traitement de l'insuffisance cerebrale
FR2635115B1 (fr) Procede de preparation de la serum albumine humaine a partir d'une levure
FR2670502B1 (fr) Cassette d'integration "multisite" dans le genome d'une levure, levure transformee et procede de preparation d'un produit d'interet par une levure ainsi transformee.
BE893492A (fr) Procede de preparation d'esters d'acides apovincaminiques, esters ainsi obtenus et compositions pharmaceutiques prepares avec ces esters
AU7394387A (en) Sialosylcholesterol, process for its preparation, and drug for treating diseases of nervous system
FR2598415B1 (fr) Procede de preparation d'un melange standard de mono-0-(b-hydroxy-ethyl)-diosmines et de di-0-(b-hydroxyethyl)-diosmine
BE891532A (fr) Procede de preparation d'ethyleneglycol et de ses ethers, et produits ainsi obtenus
FR2689876B1 (fr) Dispersions silico-acryliques, leur procédé d'obtention, leur application en stéréophotolithographie et procédé de préparation d'objets en résine.
FR2576596B1 (fr) Procede de preparation de 4,4-dialkyl-2-azetidinones, et composes nouveaux ainsi prepares
FR2606281B1 (fr) Antigene du virus de l'hepatite b et procede pour sa production
BE880732A (fr) Procede de fabrication de vaccins contre le virus de la meningoencephalite du debut de l'ete (virus fsme) et vaccins ainsi obtenus
MA20567A1 (fr) Nouveaux derives de la thierropyridine ainsi qu'un procede pour leur preparation
PT82020B (pt) Processo para a preparacao de eter 4-(2-metoxietil)-fenilglicidilico e/ou metoprolol
FR2584418B1 (fr) Anticorps monoclonaux contre le g-interferon, hybridomes produisant de tels anticorps, procede de preparation de tels anticorps et de tels hybridomes, leur utilisation pour differencier les gifs, et ensemble ou " kit " utilisant de tels anticorps
DE3565987D1 (en) Emulsion polymerization process for production of alpha-methylstyrene copolymer
EP0255755A3 (fr) Préparation de vaccin
EP0173753A4 (fr) Prostaglandines e 1 6-substituees et leur procede de preparation.
DE3668552D1 (de) Avirulenter rabies-impfstoff.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: ASTA-WERKE A.G. CHEMISCHE FABRIK

Effective date: 19840611